AU9322901A - Thrombomodulin analogs for use in recovery of signal cord injury - Google Patents

Thrombomodulin analogs for use in recovery of signal cord injury

Info

Publication number
AU9322901A
AU9322901A AU9322901A AU9322901A AU9322901A AU 9322901 A AU9322901 A AU 9322901A AU 9322901 A AU9322901 A AU 9322901A AU 9322901 A AU9322901 A AU 9322901A AU 9322901 A AU9322901 A AU 9322901A
Authority
AU
Australia
Prior art keywords
cord injury
recovery
signal cord
thrombomodulin analogs
thrombomodulin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU9322901A
Other languages
English (en)
Inventor
Barry W Festoff
Michael John Morser
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of AU9322901A publication Critical patent/AU9322901A/xx
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/366—Thrombomodulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Accommodation For Nursing Or Treatment Tables (AREA)
  • Communication Cables (AREA)
  • Signal Processing Not Specific To The Method Of Recording And Reproducing (AREA)
  • Ropes Or Cables (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU9322901A 2000-08-31 2001-08-31 Thrombomodulin analogs for use in recovery of signal cord injury Pending AU9322901A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22971400P 2000-08-31 2000-08-31
US09/938,405 US20020111296A1 (en) 2000-08-31 2001-08-23 Thrombomodulin analogs for use in recovery of spinal cord injury
PCT/US2001/041930 WO2002017953A2 (en) 2000-08-31 2001-08-31 Thrombomodulin analogs for use in recovery of signal cord injury

Publications (1)

Publication Number Publication Date
AU9322901A true AU9322901A (en) 2002-03-13

Family

ID=26923554

Family Applications (2)

Application Number Title Priority Date Filing Date
AU9322901A Pending AU9322901A (en) 2000-08-31 2001-08-31 Thrombomodulin analogs for use in recovery of signal cord injury
AU2001293229A Ceased AU2001293229B2 (en) 2000-08-31 2001-08-31 Thrombomodulin analogs for use in recovery of spinal cord injury

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2001293229A Ceased AU2001293229B2 (en) 2000-08-31 2001-08-31 Thrombomodulin analogs for use in recovery of spinal cord injury

Country Status (13)

Country Link
US (3) US20020111296A1 (enExample)
EP (1) EP1365788B1 (enExample)
JP (1) JP2004521076A (enExample)
AT (1) ATE361755T1 (enExample)
AU (2) AU9322901A (enExample)
CA (1) CA2420900A1 (enExample)
DE (1) DE60128399T2 (enExample)
DK (1) DK1365788T3 (enExample)
ES (1) ES2287161T3 (enExample)
IL (2) IL154600A0 (enExample)
NO (1) NO20030919L (enExample)
PT (1) PT1365788E (enExample)
WO (1) WO2002017953A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006005362A1 (en) * 2004-07-13 2006-01-19 Paion Deutschland Gmbh Production of mammalian proteins in plant cells
US20060148695A1 (en) * 2005-01-03 2006-07-06 National Cheng Kung University Novel angiogenic composition and use thereof
US8293710B2 (en) * 2005-01-03 2012-10-23 Blue Blood Biotech Corp. Method for treating wounds using an EGF-like domain of thrombomodulin
EP1912660A1 (en) * 2005-08-11 2008-04-23 Medigenes Co., Ltd. Pharmaceutical composition for the treatment of nerve damage comprising blood plasma or serum
AR067345A1 (es) * 2007-07-10 2009-10-07 Paion Deutschland Gmbh Uso de trombomodulina para la preparacion de un medicamento trombolitico
EP2014296A1 (en) * 2007-07-10 2009-01-14 PAION Deutschland GmbH Novel strategies for increasing the reperfusion in obstructed blood vessel
WO2010006635A1 (en) * 2008-07-16 2010-01-21 Paion Deutschland Gmbh Treatment of inflammatory bowel disease
EP2320936A1 (en) * 2008-07-16 2011-05-18 PAION Deutschland GmbH Prevention and treatment of radiation injury
DK2857037T3 (da) 2012-05-31 2019-07-22 Univ Kinki Middel til forebyggelse og/eller behandling af perifere neuropatiske smerter forårsaget af anticancerlægemiddel
CA3112679A1 (en) 2018-09-28 2020-04-02 Asahi Kasei Pharma Corporation Medicament for mitigating conditions and/or suppressing onset of peripheral neuropathy induced by anti-malignant tumor agent

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6063763A (en) * 1989-04-28 2000-05-16 Schering Aktiengesellschaft Protease-resistant thrombomodulin analogs
US5466668A (en) * 1989-04-28 1995-11-14 Schering Aktiengesellschaft Superior thrombomodulin analogs for pharmaceutical use
US5256770A (en) * 1990-04-09 1993-10-26 Schering Ag Oxidation resistant thrombomodulin analogs
JP3789147B2 (ja) * 1995-04-11 2006-06-21 旭化成ファーマ株式会社 脊髄損傷後の神経障害に対する治療剤

Also Published As

Publication number Publication date
US20090143281A1 (en) 2009-06-04
EP1365788B1 (en) 2007-05-09
DE60128399D1 (de) 2007-06-21
HK1062398A1 (en) 2004-11-05
ATE361755T1 (de) 2007-06-15
DE60128399T2 (de) 2008-01-10
JP2004521076A (ja) 2004-07-15
US20040002446A1 (en) 2004-01-01
WO2002017953A3 (en) 2003-10-09
DK1365788T3 (da) 2007-09-17
NO20030919D0 (no) 2003-02-27
CA2420900A1 (en) 2002-03-07
IL154600A (en) 2009-02-11
AU2001293229B2 (en) 2007-04-05
WO2002017953A2 (en) 2002-03-07
IL154600A0 (en) 2003-09-17
PT1365788E (pt) 2007-08-10
EP1365788A2 (en) 2003-12-03
US20020111296A1 (en) 2002-08-15
NO20030919L (no) 2003-04-10
ES2287161T3 (es) 2007-12-16

Similar Documents

Publication Publication Date Title
PL374822A1 (en) Colon cleansing compositions
SI1663185T1 (sl) Preprečevanje in zdravljenje z vnetjem inducirane in/ali imunsko posredovane izgube kosti
IL158923A0 (en) Fluoropyrrolidines as dipeptidyl peptidase inhibitors
AU3831301A (en) Method for treating ocular pain
ATE337780T1 (de) Indoly-lsulphonyl-verbindungen zur behandlung von störungen des zns
MXPA05004247A (es) Cromonas y derivados de cromona y usos de los mismos.
PL344475A1 (en) Bridged indenopyrrolocarbazoles
IL163026A (en) Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders
AU5464601A (en) Treatment of scale
IL153680A0 (en) Aplidine derivatives and methods for the preparation thereof
GB0216001D0 (en) Process and composition
UA49884C2 (uk) ПОХІДНІ <font face="Symbol">a</font>-ГІДРОКСИКАРБОНОВОЇ КИСЛОТИ ТА ЛІКАРСЬКИЙ ЗАСІБ НА ЇХ ОСНОВІ
WO2002017953A3 (en) Thrombomodulin analogs for use in recovery of signal cord injury
MX9708416A (es) Derivados de piperazino como antagonistas de neuroquininas.
GB0207653D0 (en) Methods of using lamellar bodies for therapeutic purposes
DE60110748D1 (de) Behandlung von fluorkohlenstoff-beschickungen
MXPA04003910A (es) Uso de irbesartan para la preparacion de medicamentos que son utiles para la prevencion o tratamiento de hipertension pulmonar.
EP1581209A4 (en) NEW BENZOPYRAN ANALOGUE AND ITS USE FOR THE TREATMENT OF GLAUKOM
MXPA04000272A (es) Derivados de 4-aminociclohexanol sustituidos.
PL343758A1 (en) Purification of carboxaldehyde
YU22802A (sh) Izonipekotamidi za lečenje poremećaja nastalih posredstvom integrina
AU4838301A (en) Treatment of disorders relating to the serotonergic system
PL338911A1 (en) Apparatus enabling paraparetic persons to walk
MXPA04004980A (es) Antagonistas del receptor ccr-3.
DE50006244D1 (en) Neue substituierte 3-phenoxy- und 3-phenylalkyloxy-2-phenyl-propylamine